Skip to main content
. 2018 Apr 11;9(2):175–186. doi: 10.1007/s13167-018-0131-0

Fig. 5.

Fig. 5

Principal component plot depicting both identified patient subgroup and 14 breast cancer patients. Shown is the projection of patients (indicated by numbers) on the first two principal components of the biomarker signature space. The first two principal components explain 19.6 and 9.2% of the total variance